John Scholler

14.6k citations
90 papers · 12.1k · 13 hit papers · h-index 41

Impact in

  • Oncology top 0.1%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

    • CAR-T cell therapy research 61
    • Cancer Immunotherapy and Biomarkers 4
    • Peptidase Inhibition and Analysis 3
    • T-cell and B-cell Immunology 4
    • Immunotherapy and Immune Responses 4

John Scholler

88 papers receiving 11.8k citations

John Scholler's Hit Papers

Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure 2025 · 75 citations
750+4+9Years since publication2505007501k

Peers

John Scholler
Comparison fields: 5 of 99
  • Oncology 8.5k
  • Immunology 1.6k
  • Genetics 285
  • Virology 142
  • Hematology 389
Replace Martin Pulé with:
Martin Pulé United Kingdom
Vanessa E. Gonzalez United States
Irina M. Kulikovskaya United States
Carolyn M. Laurençot United States
Megan M. Suhoski United States
Yolanda D. Mahnke United States
Rimas J. Orentas United States
Ryan Emerson United States
Zhaohui Zheng United States
Hinrich Abken Germany
John Scholler relative to Martin Pulé United Kingdom Martin Pulé's profile →
Citations per field
00.5×2×3.5×
Martin Pulé · 1×
Citations per year

Countries citing papers authored by John Scholler

Since Specialization
Citations

This map shows the geographic impact of John Scholler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Scholler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Scholler more than expected).

Fields of papers citing papers by John Scholler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Scholler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Scholler. The network helps show where John Scholler may publish in the future.

Co-authors

The 25 scholars most cited alongside John Scholler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Scholler Line = papers co-authored together John Scholler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Hit paper breakdown →
20161044
2
Targeting cardiac fibrosis with engineered T cells
Hit paper breakdown →
2019627
3
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
Hit paper breakdown →
2013581
4
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
Hit paper breakdown →
2012557
5
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Hit paper breakdown →
2018541
6
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Hit paper breakdown →
2016519
7
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Hit paper breakdown →
2016497
8
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Hit paper breakdown →
2018482
9 2015445
10 2017444
11
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Hit paper breakdown →
2022434
12 2014416
13 2015393
14 2010391
15 2015374
16
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies
Hit paper breakdown →
2020371
17 2014360
18 2014291
19 2015271
20 2018259

About John Scholler

John Scholler is a scholar working on Oncology, Immunology, Epidemiology, Genetics and Public Health, Environmental and Occupational Health, having authored 90 papers that have together received 12.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (61 papers), Trypanosoma species research and implications (6 papers), Research on Leishmaniasis Studies (5 papers), Virus-based gene therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (4 papers), Immunotherapy and Immune Responses (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (8.5k citations), Immunology (1.6k citations), Genetics (285 citations), Virology (142 citations) and Hematology (389 citations). John Scholler has collaborated with scholars based in United States, Finland and Japan. Frequent co-authors include Carl H. June, Brian Keith, Sònia Guedan, Avery D. Posey, Shannon E. McGettigan, Michael C. Milone, Steven Μ. Albelda, Omkar Uday Kawalekar, Yangbing Zhao and Regina M. Young. Their work appears in journals such as Blood, Molecular and Biochemical Parasitology, Cancer Immunology Research, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact